|
Market Closed -
Bombay S.E.
18:02:25 15/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 74.97 INR | -1.61% |
|
+1.32% | -13.68% |
Company Valuation: Astal Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 34.77 | 64.34 | 118.1 | 401.9 | 747.2 | 2,759 |
| Change | - | 85.03% | 83.54% | 240.29% | 85.93% | 269.28% |
| Enterprise Value (EV) 1 | 34.46 | 64.16 | 117.2 | 344.2 | 862.6 | 3,251 |
| Change | - | 86.18% | 82.75% | 193.57% | 150.59% | 276.91% |
| P/E | 577x | -376x | 722x | 26.3x | 9.45x | 8.37x |
| PBR | 0.67x | 1.25x | 2.27x | 1.72x | 2.08x | 0.83x |
| PEG | - | 1x | -4x | 0x | 0x | -2.89x |
| Capitalization / Revenue | 17.2x | 30.5x | 3.27x | 1.7x | 1.17x | 1.11x |
| EV / Revenue | 17.1x | 30.4x | 3.25x | 1.45x | 1.36x | 1.31x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.0152 | -0.0431 | 0.041 | 1.554 | 8.043 | 7.81 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 2.019 | 2.108 | 36.07 | 236.6 | 636.6 | 2,486 |
| EBITDA | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - |
| Net income 1 | 0.0602 | -0.1711 | 0.164 | 7.847 | 89.25 | 147.1 |
| Net Debt 1 | -0.3129 | -0.1828 | -0.844 | -57.64 | 115.4 | 491.9 |
| Reference price 2 | 8.75 | 16.19 | 29.60 | 40.88 | 76.01 | 65.36 |
| Nbr of stocks (in thousands) | 3,974 | 3,974 | 3,990 | 9,830 | 9,830 | 42,216 |
| Announcement Date | 1/9/21 | 8/9/22 | 25/8/23 | 12/7/24 | 18/8/25 | 7/9/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 34.82M | ||
| 32.41x | 11.77x | 23.88x | 0.61% | 1,015B | ||
| 29.62x | 6.59x | 18.45x | 2.02% | 642B | ||
| 33.52x | 7.76x | 16.03x | 2.62% | 463B | ||
| 19.65x | 4.78x | 11.85x | 2.77% | 353B | ||
| 19.69x | 5.14x | 12.76x | 3.13% | 265B | ||
| 21.05x | 4.32x | 12.35x | 2.04% | 254B | ||
| 24.13x | 6.36x | 11.33x | 2.64% | 206B | ||
| 12.48x | 4.54x | 9.49x | 4.03% | 191B | ||
| -44.28x | 6.46x | 25.23x | 2.25% | 182B | ||
| Average | 16.47x | 6.41x | 15.71x | 2.46% | 357.03B | |
| Weighted average by Cap. | 23.59x | 7.64x | 17.62x | 2.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MACINTR Stock
- Valuation Astal Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















